Biotech Values

[DewDiligence]

ENTA should have ample news flow in September insofar as ABBV’s SAPHIRE-1 and -2 studies are scheduled to report top-line data (see listing in #msg-90408583).

Moreover, ENTA will be increasing its visibility during September by participating in three investor conferences: Citi on 9/3, Morgan Stanley on 9/11, and Stifel Nicolaus on 9/12. This is a pretty big change for a company that has, until now, maintained a low profile by not even holding quarterly conference calls since its IPO in Mar 2013.